Evaluated articles

Showing page 30 of 34 pages of list content

We couldn't get details of this article at this time:
10.1101/2021.10.07.21264626
We couldn't get details of this article at this time:
10.1101/2021.09.24.21264045
We couldn't get details of this article at this time:
10.1101/2021.09.10.21263072
We couldn't get details of this article at this time:
10.1101/2021.08.25.21262636
We couldn't get details of this article at this time:
10.1101/2021.07.05.21260003
We couldn't get details of this article at this time:
10.1101/2020.05.22.111344
Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs

This article has 8 authors:
1. Irina Kislaya
2. Eduardo Freire Rodrigues
3. Vítor Borges
4. João Paulo Gomes
5. Carlos Sousa
6. José Pedro Almeida
7. André Peralta-Santos
8. Baltazar Nunes
Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

This article has 4 evaluationsAppears in 2 listsLatest version Aug 22, 2021Latest activity Sep 27, 2021
We couldn't get details of this article at this time:
10.1101/2021.08.13.21261983
We couldn't get details of this article at this time:
10.1101/2021.08.17.21262169
We couldn't get details of this article at this time:
10.1101/2021.05.05.21256681
We couldn't get details of this article at this time:
10.1101/2021.05.04.442663
Anti-PF4 levels of patients with VITT do not reduce 4 months following AZD1222 vaccination

This article has 9 authors:
1. Phillip L.R. Nicolson
2. Samantha J. Montague
3. Christopher W. Smith
4. Clare S. Lodwick
5. Charlotte Stoneley
6. Matthew Roberts
7. Steve P. Watson
8. Gillian C. Lowe
9. William A. Lester
Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

This article has 5 evaluationsAppears in 2 listsLatest version Aug 23, 2021Latest activity Sep 14, 2021
We couldn't get details of this article at this time:
10.1101/2021.05.12.21257080
We couldn't get details of this article at this time:
10.1101/2021.06.05.447177
Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release

This article has 15 authors:
1. Hazel Stewart
2. Roberta Palmulli
3. Kristoffer H Johansen
4. Naomi McGovern
5. Ola M Shehata
6. George W Carnell
7. Hannah K Jackson
8. Jin S Lee
9. Jonathan C Brown
10. Thomas Burgoyne
11. Jonathan L Heeney
12. Klaus Okkenhaug
13. Andrew E Firth
14. Andrew A Peden
15. James R Edgar
Reviewed by Review Commons, Rapid Reviews Infectious Diseases, ScreenIT

This article has 8 evaluationsAppears in 4 listsLatest version Oct 11, 2023Latest activity Mar 15, 2023
We couldn't get details of this article at this time:
10.1101/2021.06.28.21259673
We couldn't get details of this article at this time:
10.1101/2020.10.21.20217208
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers

This article has 31 authors:
1. Si’Ana A Coggins
2. Eric D Laing
3. Cara H Olsen
4. Emilie Goguet
5. Matthew Moser
6. Belinda M Jackson-Thompson
7. Emily C Samuels
8. Simon D Pollett
9. David R Tribble
10. Julian Davies
11. Luca Illinik
12. Monique Hollis-Perry
13. Santina E Maiolatesi
14. Christopher A Duplessis
15. Kathleen F Ramsey
16. Anatalio E Reyes
17. Yolanda Alcorta
18. Mimi A Wong
19. Gregory Wang
20. Orlando Ortega
21. Edward Parmelee
22. Alyssa R Lindrose
23. Andrew L Snow
24. Allison M W Malloy
25. Andrew G Letizia
26. Daniel Ewing
27. John H Powers
28. Kevin L Schully
29. Timothy H Burgess
30. Christopher C Broder
31. Edward Mitre
Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

This article has 4 evaluationsAppears in 2 listsLatest version Nov 20, 2021Latest activity Aug 4, 2021
We couldn't get details of this article at this time:
10.1101/2021.05.26.445185
Variants in SARS-CoV-2 associated with mild or severe outcome

This article has 7 authors:
1. Jameson D Voss
2. Martin Skarzynski
3. Erin M McAuley
4. Ezekiel J Maier
5. Thomas Gibbons
6. Anthony C Fries
7. Richard R Chapleau
Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

This article has 4 evaluationsAppears in 2 listsLatest version Jan 1, 2021Latest activity Jul 5, 2021

Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs

Anti-PF4 levels of patients with VITT do not reduce 4 months following AZD1222 vaccination

Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release

Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers

Variants in SARS-CoV-2 associated with mild or severe outcome